Bank Of New Hampshire Amgen Inc Transaction History

Bank Of New Hampshire

  • $383 Million
  • Q2 2024

A detailed history of Bank Of New Hampshire transactions in Amgen Inc stock. As of the latest transaction made, Bank Of New Hampshire holds 1,597 shares of AMGN stock, worth $494,079. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,597
Previous 1,678 4.83%
Holding current value
$494,079
Previous $477,000 4.4%
% of portfolio
0.13%
Previous 0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 01, 2024
SELL
$262.75 - $319.31 $21,282 - $25,864
-81 Reduced 4.83%
1,597 $498,000
Q1 2024

Apr 10, 2024
SELL
$268.87 - $324.56 $42,481 - $51,280
-158 Reduced 8.61%
1,678 $477,000
Q4 2023

Feb 02, 2024
SELL
$255.7 - $288.46 $116,087 - $130,960
-454 Reduced 19.83%
1,836 $528,000
Q3 2023

Oct 10, 2023
SELL
$218.65 - $271.46 $19,678 - $24,431
-90 Reduced 3.78%
2,290 $615,000
Q2 2023

Jul 28, 2023
SELL
$214.27 - $253.37 $11,784 - $13,935
-55 Reduced 2.26%
2,380 $528,000
Q1 2023

Apr 04, 2023
SELL
$225.79 - $275.2 $7,676 - $9,356
-34 Reduced 1.38%
2,435 $588,000
Q4 2022

Jan 10, 2023
SELL
$229.03 - $291.01 $10,764 - $13,677
-47 Reduced 1.87%
2,469 $648,000
Q3 2022

Oct 24, 2022
SELL
$224.46 - $253.15 $9,651 - $10,885
-43 Reduced 1.68%
2,516 $567,000
Q2 2022

Jul 08, 2022
SELL
$230.71 - $256.74 $30,915 - $34,403
-134 Reduced 4.98%
2,559 $623,000
Q1 2022

Apr 20, 2022
SELL
$219.27 - $242.57 $877 - $970
-4 Reduced 0.15%
2,693 $651,000
Q4 2021

Jan 12, 2022
SELL
$198.88 - $227.6 $836,688 - $957,513
-4,207 Reduced 60.94%
2,697 $606,000
Q2 2021

Jul 06, 2021
BUY
$233.58 - $259.14 $1.61 Million - $1.79 Million
6,904 New
6,904 $1.68 Million

Others Institutions Holding AMGN

# of Institutions
2,933
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $165B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email